{"Assessment": [0], "of": [1, 6, 25, 28, 35], "the": [2, 9, 26, 29, 38], "safety": [3], "and": [4], "efficacy": [5, 27], "vaccines": [7, 30], "against": [8, 31], "severe": [10], "acute": [11], "respiratory": [12], "syndrome": [13], "coronavirus": [14], "2": [15], "(SARS-CoV-2)": [16], "in": [17, 44], "different": [18], "populations": [19], "is": [20, 23], "essential,": [21], "as": [22], "investigation": [24], "emerging": [32], "SARS-CoV-2": [33], "variants": [34], "concern,": [36], "including": [37], "B.1.351": [39], "(501Y.V2)": [40], "variant": [41], "first": [42], "identified": [43], "South": [45], "Africa.": [46]}